Cargando…

A Scoring Method to Prioritize Fecal Occult Blood Testing as a First Step in Colorectal Cancer Screening in Resource-Limited Settings

This study aims to develop a scoring method that can be used by primary care physicians from remote areas or resource-limited settings to estimate the need for fecal occult blood testing (FOBT) as a first step in colorectal cancer screening. This method relies on several modifiable risk factors that...

Descripción completa

Detalles Bibliográficos
Autores principales: Bărbulescu, Linda-Nicoleta, Rădulescu, Virginia-Maria, Mogoantă, Stelian-Ștefăniță, Bărbulescu, Lucian-Florentin, Kamal, Constantin, Radu, Mirela, Cismaru, Liana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417455/
https://www.ncbi.nlm.nih.gov/pubmed/37568919
http://dx.doi.org/10.3390/diagnostics13152556
_version_ 1785088039757807616
author Bărbulescu, Linda-Nicoleta
Rădulescu, Virginia-Maria
Mogoantă, Stelian-Ștefăniță
Bărbulescu, Lucian-Florentin
Kamal, Constantin
Radu, Mirela
Cismaru, Liana
author_facet Bărbulescu, Linda-Nicoleta
Rădulescu, Virginia-Maria
Mogoantă, Stelian-Ștefăniță
Bărbulescu, Lucian-Florentin
Kamal, Constantin
Radu, Mirela
Cismaru, Liana
author_sort Bărbulescu, Linda-Nicoleta
collection PubMed
description This study aims to develop a scoring method that can be used by primary care physicians from remote areas or resource-limited settings to estimate the need for fecal occult blood testing (FOBT) as a first step in colorectal cancer screening. This method relies on several modifiable risk factors that can influence a positive FOBT, an indication of the presence of colorectal polyps, or even colorectal cancer. The scoring method considers, besides the age and gender of the patient, the body mass index (BMI), smoking status, and the diagnoses of diabetes mellitus (type 2 diabetes), dyslipidemia, and hypertension. It does not need any paraclinical exams, which is an advantage when access or material resources are limited. The retrospective study was spread over forty-three months, respectively, from October 2019 to April 2023, and included 112 patients. The score that we designed is a numerical value between 0 and 7. The values between 0 and 3 represent a smaller risk of a positive FOBT (9.68%), values 4 and 5 represent a medium risk (14.75%), while values 6 and 7 represent a greater risk (40%). Using this score, a physician can determine if a patient has a greater risk and recommend it to prioritize taking a FOB test.
format Online
Article
Text
id pubmed-10417455
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104174552023-08-12 A Scoring Method to Prioritize Fecal Occult Blood Testing as a First Step in Colorectal Cancer Screening in Resource-Limited Settings Bărbulescu, Linda-Nicoleta Rădulescu, Virginia-Maria Mogoantă, Stelian-Ștefăniță Bărbulescu, Lucian-Florentin Kamal, Constantin Radu, Mirela Cismaru, Liana Diagnostics (Basel) Article This study aims to develop a scoring method that can be used by primary care physicians from remote areas or resource-limited settings to estimate the need for fecal occult blood testing (FOBT) as a first step in colorectal cancer screening. This method relies on several modifiable risk factors that can influence a positive FOBT, an indication of the presence of colorectal polyps, or even colorectal cancer. The scoring method considers, besides the age and gender of the patient, the body mass index (BMI), smoking status, and the diagnoses of diabetes mellitus (type 2 diabetes), dyslipidemia, and hypertension. It does not need any paraclinical exams, which is an advantage when access or material resources are limited. The retrospective study was spread over forty-three months, respectively, from October 2019 to April 2023, and included 112 patients. The score that we designed is a numerical value between 0 and 7. The values between 0 and 3 represent a smaller risk of a positive FOBT (9.68%), values 4 and 5 represent a medium risk (14.75%), while values 6 and 7 represent a greater risk (40%). Using this score, a physician can determine if a patient has a greater risk and recommend it to prioritize taking a FOB test. MDPI 2023-08-01 /pmc/articles/PMC10417455/ /pubmed/37568919 http://dx.doi.org/10.3390/diagnostics13152556 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bărbulescu, Linda-Nicoleta
Rădulescu, Virginia-Maria
Mogoantă, Stelian-Ștefăniță
Bărbulescu, Lucian-Florentin
Kamal, Constantin
Radu, Mirela
Cismaru, Liana
A Scoring Method to Prioritize Fecal Occult Blood Testing as a First Step in Colorectal Cancer Screening in Resource-Limited Settings
title A Scoring Method to Prioritize Fecal Occult Blood Testing as a First Step in Colorectal Cancer Screening in Resource-Limited Settings
title_full A Scoring Method to Prioritize Fecal Occult Blood Testing as a First Step in Colorectal Cancer Screening in Resource-Limited Settings
title_fullStr A Scoring Method to Prioritize Fecal Occult Blood Testing as a First Step in Colorectal Cancer Screening in Resource-Limited Settings
title_full_unstemmed A Scoring Method to Prioritize Fecal Occult Blood Testing as a First Step in Colorectal Cancer Screening in Resource-Limited Settings
title_short A Scoring Method to Prioritize Fecal Occult Blood Testing as a First Step in Colorectal Cancer Screening in Resource-Limited Settings
title_sort scoring method to prioritize fecal occult blood testing as a first step in colorectal cancer screening in resource-limited settings
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417455/
https://www.ncbi.nlm.nih.gov/pubmed/37568919
http://dx.doi.org/10.3390/diagnostics13152556
work_keys_str_mv AT barbulesculindanicoleta ascoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT radulescuvirginiamaria ascoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT mogoantastelianstefanita ascoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT barbulesculucianflorentin ascoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT kamalconstantin ascoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT radumirela ascoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT cismaruliana ascoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT barbulesculindanicoleta scoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT radulescuvirginiamaria scoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT mogoantastelianstefanita scoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT barbulesculucianflorentin scoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT kamalconstantin scoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT radumirela scoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings
AT cismaruliana scoringmethodtoprioritizefecaloccultbloodtestingasafirststepincolorectalcancerscreeninginresourcelimitedsettings